Innovator Biologics, Biosimilars and Biobetters : Terminology, Nomenclature and Definitions -- Approved Biologic Medicines and Biosimilars in Major Regulatory Jurisdictions -- Status of Biologic Drugs in Modern Therapeutics-Targeted Therapies vs Small Molecule Drugs -- Major Classes of Biotherapeutics -- Drug Targets for Biologics -- Pivotal Biology, Chemistry, Biochemistry and Biophysical Concepts of Biologics and Biosimilars -- Biosimilarity and Interchangeability of Biologic Drugs- General Principles, Biophysical Tests and Clinical Requirements to Demonstrate Biosimilarity -- Pharmacokinetics of Biologics -- Pharmacogenomics of Biologics -- International Regulatory Processes and Policies for Innovator Biologics, Biosimilars and Biobetters -- Pharmacovigilance of Innovator Biologics and Biosimilars -- Pharmacoeconomics of Biologic Medicines and Biosimilars / Gregory Reardon -- New Emerging Biotherapies : Cutting-Edge Research to Experimental Therapies -- Optimising Use of Biologic Medicines Using a Quality Use of Medicines Approach -- Knowledge Areas and Competency Standards on Biologic Medicines for Pharmacists and Pharmacy Students -- A Checklist for Pharmacists on Biologics and Biosimilars -- Tips to Enhance Patient-Centred Discussions.